Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284643145> ?p ?o ?g. }
- W2284643145 endingPage "83" @default.
- W2284643145 startingPage "467" @default.
- W2284643145 abstract "Mounting evidence suggests that lipoxygenase (LO)-catalyzed products have a profound influence on the development and progression of human cancers. Compared with normal tissues, significantly elevated levels of LO metabolites have been found in lung, prostate, breast, colon, and skin cancer cells, as well as in cells from patients with both acute and chronic leukemias. LO-mediated products elicit diverse biological activities needed for neoplastic cell growth, influencing growth factor and transcription factor activation, oncogene induction, stimulation of tumor cell adhesion, and regulation of apoptotic cell death. Agents that block LO-catalyzed activity may be effective in preventing cancer by interfering with signaling events needed for tumor growth. In fact, in a few studies, LO inhibitors have prevented carcinogen-induced lung adenomas and rat mammary gland cancers. During the past 10 years, pharmacological agents that specifically inhibit the LO-mediated signaling pathways are now commercially available to treat inflammatory diseases such as asthma, arthritis, and psoriasis. These well-characterized agents, representing two general drug effect mechanisms, are considered good candidates for clinical chemoprevention studies. One mechanism is inhibition of LO activity (5-LO and associated enzymes, or 12-LO); the second is leukotriene receptor antagonism. Although the receptor antagonists have high potential in treating asthma and other diseases where drug effects are clearly mediated by the leukotriene receptors, enzyme activity inhibitors may be better candidates for chemopreventive intervention, because inhibition of these enzymes directly reduces fatty acid metabolite production, with concomitant damping of the associated inflammatory, proliferative, and metastatic activities that contribute to carcinogenesis. However, because receptor antagonists have aerosol formulations and possible antiproliferative activity, they may also have potential, particularly in the lung, where topical application of such formulations is feasible." @default.
- W2284643145 created "2016-06-24" @default.
- W2284643145 creator A5008269920 @default.
- W2284643145 creator A5014024059 @default.
- W2284643145 creator A5014553553 @default.
- W2284643145 creator A5015008352 @default.
- W2284643145 creator A5017000224 @default.
- W2284643145 creator A5048308941 @default.
- W2284643145 creator A5051957313 @default.
- W2284643145 creator A5059928711 @default.
- W2284643145 date "1999-05-01" @default.
- W2284643145 modified "2023-10-03" @default.
- W2284643145 title "Lipoxygenase inhibitors as potential cancer chemopreventives." @default.
- W2284643145 cites W1024647450 @default.
- W2284643145 cites W117850 @default.
- W2284643145 cites W1210312461 @default.
- W2284643145 cites W146276655 @default.
- W2284643145 cites W1490845266 @default.
- W2284643145 cites W1492551494 @default.
- W2284643145 cites W1494869915 @default.
- W2284643145 cites W1495722852 @default.
- W2284643145 cites W1509307264 @default.
- W2284643145 cites W1510480381 @default.
- W2284643145 cites W1521799099 @default.
- W2284643145 cites W1525334726 @default.
- W2284643145 cites W1540547861 @default.
- W2284643145 cites W1567023633 @default.
- W2284643145 cites W1567180128 @default.
- W2284643145 cites W1573542905 @default.
- W2284643145 cites W1580797218 @default.
- W2284643145 cites W1584053655 @default.
- W2284643145 cites W1599688047 @default.
- W2284643145 cites W1605709450 @default.
- W2284643145 cites W1610468465 @default.
- W2284643145 cites W161998395 @default.
- W2284643145 cites W1624875646 @default.
- W2284643145 cites W1795737554 @default.
- W2284643145 cites W1798670389 @default.
- W2284643145 cites W180357471 @default.
- W2284643145 cites W1816377767 @default.
- W2284643145 cites W1852699347 @default.
- W2284643145 cites W1924846213 @default.
- W2284643145 cites W1938617858 @default.
- W2284643145 cites W1940051259 @default.
- W2284643145 cites W1941276656 @default.
- W2284643145 cites W1941476277 @default.
- W2284643145 cites W1942988316 @default.
- W2284643145 cites W1954943746 @default.
- W2284643145 cites W1963614163 @default.
- W2284643145 cites W1964302399 @default.
- W2284643145 cites W1964368363 @default.
- W2284643145 cites W1965551017 @default.
- W2284643145 cites W1966077390 @default.
- W2284643145 cites W1966164413 @default.
- W2284643145 cites W1968792529 @default.
- W2284643145 cites W1968998478 @default.
- W2284643145 cites W1973538216 @default.
- W2284643145 cites W1973820835 @default.
- W2284643145 cites W1975517899 @default.
- W2284643145 cites W1978000487 @default.
- W2284643145 cites W1980556103 @default.
- W2284643145 cites W1980832959 @default.
- W2284643145 cites W1981601059 @default.
- W2284643145 cites W1981883990 @default.
- W2284643145 cites W1982349613 @default.
- W2284643145 cites W1982407164 @default.
- W2284643145 cites W1986155420 @default.
- W2284643145 cites W1986305114 @default.
- W2284643145 cites W1987883076 @default.
- W2284643145 cites W1988278959 @default.
- W2284643145 cites W1988491976 @default.
- W2284643145 cites W1993058070 @default.
- W2284643145 cites W1994209871 @default.
- W2284643145 cites W1994378821 @default.
- W2284643145 cites W1994730705 @default.
- W2284643145 cites W1995680891 @default.
- W2284643145 cites W1996467233 @default.
- W2284643145 cites W1996663775 @default.
- W2284643145 cites W1999744355 @default.
- W2284643145 cites W1999783546 @default.
- W2284643145 cites W2003394832 @default.
- W2284643145 cites W2004525168 @default.
- W2284643145 cites W2004740907 @default.
- W2284643145 cites W2004885595 @default.
- W2284643145 cites W2005870570 @default.
- W2284643145 cites W2007096194 @default.
- W2284643145 cites W2007253276 @default.
- W2284643145 cites W2007278554 @default.
- W2284643145 cites W2008057379 @default.
- W2284643145 cites W2008078445 @default.
- W2284643145 cites W2008081889 @default.
- W2284643145 cites W2010287717 @default.
- W2284643145 cites W2012582175 @default.
- W2284643145 cites W2012831582 @default.
- W2284643145 cites W2014240993 @default.
- W2284643145 cites W2016550350 @default.
- W2284643145 cites W2016804723 @default.
- W2284643145 cites W2018208300 @default.